Disease With CTCA) trial.
coronary heart disease to the emergency department.
This is an important and major addition to the spectrum of recent trials assessing the impact of coronary CTA in patients with stable and those with unstable coronary heart disease ( Figure 1) . The major strengths of this study were that all patients underwent coronary CTA (although analysis of coronary CTA was prohibited in the control group until study completion), patient care pathways were transformed into protocols, and follow-up was comprehensive and robust. They report that coronary CTA was associated Recent clinical trials of coronary computed tomography angiography (CTA) across the spectrum of coronary heart disease (CHD).
Newby and Gray will now need to re-evaluate the priority and place of coronary CTA which has had to prove its worth more than any other imaging modality to date. 
